Suppr超能文献

[体外循环下心内直视手术后的凝血功能障碍及出血后果]

[Coagulation deficits and hemorrhagic consequences after cardiac surgery under ECC].

作者信息

Belleville J, Paul J, Ollat G, Broyer P

出版信息

Ann Anesthesiol Fr. 1977;18(1):51-61.

PMID:16544
Abstract

I--A statistical study of the results of tests of hemostasis was carried out in patients who had undergone major cardiac surgery with extra-corporeal circulation. There were two series of patients (1.504 and 547 operated) suffering mainly from congenital cardiopathies, valvulopathies or coronaritis. Bearing in mind the hematocrit and the total protein level, the following was studied before and after ECC and 24 hours after the intervation: the blood platelet level, fibrinogen, prothrombin and its cofactors, antithemophilic factors A and B, FDP amd fibrinolytic activity. The fall in platelet stickiness is specifically pointed out, and also the fall in the level of fibrin stablizing factor (factor XIII) which is met with after ECC, and which can explain the persistence of certain hemorrhagies. Furthermore, the fall in antithrombin III level then its rise can contribute to the "heparine rebound" occurring in certain cases after neutralization of heparinemia with protamine. II--The deficits in the quantitatively and qualitatively variable hemostatic factors do not necessarily lead to hemorrhage. Hemorrhage, due to biological causes, are met with in 5 to 6 p. 100 of the cases. Most of the time they are provoked by a residual hemorrhage or a "heparine rebound", deficits in coagulation factors, a DIVC syndrome, difficult to diagnose and to treat, or fibrinolysis, much more rarely nowadays, owing to the almost routine use of antiproteases. Sometimes, the check up of coagulation can be barely disturbed and local abnormalities in biological hemostasis which are still not well understood, are invoked in order to explain the hemorrhage.

摘要

一、对接受体外循环心脏大手术患者的止血测试结果进行了统计学研究。有两组患者(分别为1504例和547例接受手术),主要患有先天性心脏病、瓣膜病或冠状动脉炎。考虑到血细胞比容和总蛋白水平,在体外循环前后以及干预后24小时对以下指标进行了研究:血小板水平、纤维蛋白原、凝血酶原及其辅因子、抗血友病因子A和B、纤维蛋白降解产物(FDP)以及纤溶活性。特别指出了血小板黏附性的下降,以及体外循环后出现的纤维蛋白稳定因子(因子XIII)水平的下降,这可以解释某些出血的持续存在。此外,抗凝血酶III水平先下降后上升,这可能导致在某些情况下用鱼精蛋白中和肝素血症后出现“肝素反弹”。二、止血因子在数量和质量上的变化所导致的缺陷不一定会引起出血。因生物学原因导致的出血在5%至6%的病例中出现。大多数情况下,出血是由残余出血或“肝素反弹”、凝血因子缺乏、弥散性血管内凝血(DIVC)综合征(难以诊断和治疗)或纤维蛋白溶解引起的,如今由于几乎常规使用抗蛋白酶,纤维蛋白溶解导致出血的情况更为罕见。有时,凝血检查几乎不受干扰,人们会援引生物止血方面仍未完全了解的局部异常情况来解释出血。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验